These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25697566)

  • 1. Dipyridamole: a drug with unrecognized antioxidant activity.
    Ciacciarelli M; Zerbinati C; Violi F; Iuliano L
    Curr Top Med Chem; 2015; 15(9):822-9. PubMed ID: 25697566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipyridamole, cerebrovascular disease, and the vasculature.
    Chakrabarti S; Freedman JE
    Vascul Pharmacol; 2008; 48(4-6):143-9. PubMed ID: 18342579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?
    Balakumar P; Nyo YH; Renushia R; Raaginey D; Oh AN; Varatharajan R; Dhanaraj SA
    Pharmacol Res; 2014 Sep; 87():144-50. PubMed ID: 24861566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus.
    Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1104-10. PubMed ID: 9563726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
    Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
    Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole.
    Gamboa A; Abraham R; Diedrich A; Shibao C; Paranjape SY; Farley G; Biaggioni I
    Stroke; 2005 Oct; 36(10):2170-5. PubMed ID: 16141426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole, an underestimated vascular protective drug.
    Schaper W
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):357-63. PubMed ID: 16382298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischaemia-reperfusion-induced damage.
    Bertuglia S; Giusti A; Fedele S; Picano E
    Diabetologia; 2001 Dec; 44(12):2165-70. PubMed ID: 11793017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in vasodilatory response to dipyridamole between patients with angina and normal coronary arteries and patients with successful coronary angioplasty.
    Finocchiaro ML; Buffon A; Beltrame JF; Lupi A; Conti E; Lanza GA; Cianflone D; Crea F; Maseri A
    Coron Artery Dis; 1995 Jun; 6(6):479-87. PubMed ID: 7551269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects.
    Chakrabarti S; Blair P; Wu C; Freedman JE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):449-57. PubMed ID: 18049314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of coumarins besides their antioxidant activity.
    Najmanová I; Doseděl M; Hrdina R; Anzenbacher P; Filipský T; Říha M; Mladěnka P
    Curr Top Med Chem; 2015; 15(9):830-49. PubMed ID: 25697565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of i.v. dipyridamole on cerebral blood flow, blood pressure, plasma adenosine and cAMP levels in rabbits.
    Hegedüs K; Keresztes T; Fekete I; Molnár L
    J Neurol Sci; 1997 May; 148(2):153-61. PubMed ID: 9129111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational therapeutics of dipyridamole.
    Kim HH; Liao JK
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s39-42. PubMed ID: 18174451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dipyridamole on vascular cell-derived reactive oxygen species.
    Chakrabarti S; Vitseva O; Iyu D; Varghese S; Freedman JE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):494-500. PubMed ID: 16046616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy with NO donors-antiatherogenic and antioxidant actions].
    Grosser N; Schröder H
    Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole inhibits PDGF- and bFGF-induced vascular smooth muscle cell proliferation.
    Himmelfarb J; Couper L
    Kidney Int; 1997 Dec; 52(6):1671-7. PubMed ID: 9407516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.
    Zhuplatov SB; Masaki T; Blumenthal DK; Cheung AK
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):431-9. PubMed ID: 17169124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant effect of dipyridamole and its derivative RA-25 in mitochondria: correlation of activity and location in the membrane.
    Nepomuceno MF; de Oliveira Mamede ME; Vaz de Macedo D; Alves AA; Pereira-da-Silva L; Tabak M
    Biochim Biophys Acta; 1999 May; 1418(2):285-94. PubMed ID: 10320680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.